Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Joshua Resnick currently holds 17,340 shares of KalVista Pharmaceuticals, Inc. (KALV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joshua Resnick has been a net neutral trader of KALV stock. They have purchased $0 and sold $0 worth of shares.
Joshua Resnick's most recent insider trade was on Jun 17, 2026, when they sold 17,340 shares at $0.00 per share.
Joshua Resnick serves as Executive at KalVista Pharmaceuticals, Inc. (KALV). They have executed 6 insider transactions totaling $0 over their tenure at the company.
Joshua Resnick holds the position of Executive at KalVista Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Joshua Resnick has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Joshua Resnick was on Jun 17, 2026, when they purchased $0 worth of SION shares. This transaction involved 17,340 shares at N/A per share.
Joshua Resnick currently owns 17,340 shares of KalVista Pharmaceuticals, Inc. (KALV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Joshua Resnick's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Joshua Resnick has 6 Form 4 filings on record as an insider at KalVista Pharmaceuticals, Inc..
Set alerts for Joshua Resnick and 40,000+ other insiders.